Twist Bioscience Climbs to $101.83 Amid Bullish Momentum

Twist Bioscience stock is edging higher to $101.83 as a bullish trend continues to build momentum for the synthetic biology company. The stock's relative strength index is approaching overbought territory, signaling strong buying pressure and investor enthusiasm. The move reflects growing confidence in Twist's business prospects and the broader biotech sector's recovery. Traders are watching closely to see if the stock can sustain its gains or if profit-taking emerges at these elevated levels.